PARDES BIOSCIENCES, INC.
DelistedCIK 1822711fmd_0JFN4AD1592M672QVRFVVCEPSRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Jun 30, 2023, 10 periods
| Line item | FY2021 | FY2022 |
|---|---|---|
| Total revenues | 0 | 0 |
| Net interest income | (0) | 3 |
| Research and development | 28 | 70 |
| Total operating expenses | 38 | 100 |
| Operating income | 38 | – |
| Income tax expense | 0 | 0 |
| Net income | (39) | (97) |